EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Clinical Cancer Research

ISSN 1078-0432 · American Association for Cancer Research (AACR)

Neueste Artikel

  1. Second- and Third-Line Outcomes after Selective RET Inhibitor Failure in RET Fusion-Positive Metastatic Lung Cancer: A Real-World Analysis from the RET-MAP Registry

    Daniela Miliziano, Julia K. Rotow, Meghanne Lomibao, Arianna Marinello, Helena Bote-de Cabo, Fabrizio Citarella, Lorenza Landi, Massimiliano Cani, Mariana Brandão, Jamie Feng, Sophie Cousin, Andrea De Giglio, Marco Tagliamento, Philippe Rochigneux, Florian Guisier, Lea Ruge, Annarita Avanzo, Francesca Colamartini, Francesco Cortiula, Vladmir Cordeiro de Lima, Antonio Calles, Patricia Iranzo, Barliz Waissengrin, Clarisse Audigier-Valette, Frank Aboubakar, Noemie Simon-Tillaux, Vinicius Ernani, Jordi Remon, Alessio Cortellini, David Planchard, Biagio Ricciuti, Benjamin Besse, Petros Christopoulos, Alexander Drilon, Mihaela Aldea

    Erschienen: 2026-11-12DOI: 10.1158/1078-0432.ccr-26-2942

  2. Targeting DHFR to suppress one-carbon metabolism and enhance radiation sensitivity in patients with NRF2-active head and neck squamous cell carcinoma

    Paul Zolkind, Emily M. Wilkerson, Harit Panda, Julius Chembo, James Sun, Kate Zhao, Jessica Ley, Michael Atteberry, Kevin Cho, Nathan T. Wamsley, Dennis Goldfarb, Kynlee G. Giesie, Joe C. Major, Xiaoxin Chen, Ryan S. Jackson, Jason T. Rich, Patrik Pipkorn, R. Alex Harbison, Ben Wahle, Anthony J. Apicelli, Jennifer De Los Santos, Wade L. Thorstad, Gary J. Patti, Sidharth V. Puram, Peter Oppelt, Doug Adkins, Michael B. Major

    Erschienen: 2026-11-11DOI: 10.1158/1078-0432.ccr-26-0700

  3. SPROUT Guidelines for Molecular Profiling for Children with Solid Tumors: A Consensus Recommendation from the American Association for Cancer Research

    Catherine Gestrich, Larissa V. Furtado, Jaclyn Biegel, Maryam Fouladi, Andrew L. Kung, Theodore W. Laetsch, Sarah Leary, Marilyn M. Li, Elaine Mardis, David Malkin, Alberto S. Pappo, Donald W. Parsons, Angshumoy Roy, Erin Rudzinski, Jack F. Shern, Adam Shlien, Neerav Shukla, Katherine A. Janeway, Alanna J. Church

    Erschienen: 2026-11-11DOI: 10.1158/1078-0432.ccr-26-1643

  4. Anti-TNFR2 Antibody BI-1808 Induces Tumor Regression and Antitumor T-cell Immunity through Treg and Myeloid Cell Modulation in Patients with Solid Tumors

    Ingrid Teige, Kristoffer S. Rohrberg, Ana Carneiro, Jeffrey Yachnin, Susanne Gertsson, Petra Holmkvist, Linda Mårtensson, Rikke L. Eefsen, Zsuzsanna Pápai, István Láng, Harriet Walter, Marie Borggren, Marica Vaapil, Jan Anders Nilsson, Carolin Svensson, Mathilda Kovacek, Therese Blidberg, Kirstie Cleary, Robert J. Oldham, Alexandra Gabriela Ferreira, Benjamin L. Duell, Anette Sundstedt, Niyaz Yoosuf, Monika Semmrich, Danijela Lindahl, Stephen A. Beers, Sean H. Lim, Johan Wallin, Ingrid Karlsson, Mark S. Cragg, Björn Frendéus, Andres McAllister

    Erschienen: 2026-11-11DOI: 10.1158/1078-0432.ccr-26-2049

  5. Phase I Trial and Biomarker Analysis of Buparlisib with Weekly Cisplatin and Radiotherapy in High-risk Locally Advanced Squamous Cell Cancer of the Head and Neck

    Jochen H. Lorch, Kristine Wong, Roy B. Tishler, Robert I. Haddad, Anne O’Neill, Kee-Young Shin, Mofei Liu, Glenn J. Hanna, Nicole G. Chau, Guilherme Rabinowits, Jonathan D. Schoenfeld, Danielle N. Margalit, Laura Goguen, Ravindra Uppaluri, Tom Thomas, Alec Kacew, Patricia McHugh, Ethan Harris, Kimberly Austin, Julian Huang, Umair Mahmood, Bose S. Kochupurakkal, Lynette M. Sholl, Jennifer M. Spangle

    Erschienen: 2026-11-06DOI: 10.1158/1078-0432.ccr-21-3677

  6. Multiomics Analysis of Malignant Pleural Mesothelioma Reveals the Immunological Microenvironment Associated with MTAP Loss and Immunotherapy Outcomes

    Akiko Tateishi, Tatsuya Yoshida, Kouya Shiraishi, Yuji Uehara, Kentaro Gosho, Jun Miyakoshi, Masahiro Torasawa, Yukiko Shimoda. Igawa, Rui Kitadai, Yukihiro Yoshida, Yuki Shinno, Yuji Matsumoto, Yusuke Okuma, Tomonori Mizutani, Hidehito Horinouchi, Takafumi Koyama, Shun-ichi Watanabe, Yasushi Yatabe, Noboru Yamamoto, Takashi Kohno, Yasushi Goto

    Erschienen: 2026-11-06DOI: 10.1158/1078-0432.ccr-26-1855

  7. DNA-Based Biomarkers as Predictors of Carboplatin Response in Neoadjuvant Treatment for Hormone Receptor-Positive and Triple-Negative Breast Cancer

    Arne V. Pladsen, Marianne L. Smebye, Øystein Garred, Elin Borgen, Eivind V. Egeland, Mads H. Haugen, Maria A. Dahle, Lina Prasmickaite, Gunhild M. Mælandsmo, Eivind Hovig, Sigve Nakken, Alexandra Østgaard, Inger R. Bergheim, Kristin V. Reinertsen, Hege Oma Ohnstad, Ellen Schlichting, Helle K. Skjerven, Anne-Lise Børresen-Dale, Erik Wist, Bjørn Naume, Hege G. Russnes, Ole Christian Lingjærde, Olav Engebraaten

    Erschienen: 2026-11-06DOI: 10.1158/1078-0432.ccr-26-2212

  8. A Phase II Study of Nivolumab and Ipilimumab with Radiotherapy in Patients with Metastatic, Microsatellite-Stable Colorectal Cancer

    Leontios Pappas, Julie L. Koenig, Beow Y. Yeap, Jeffrey W. Clark, Samuel J. Klempner, David P. Ryan, Jill N. Allen, Lawrence S. Blaszkowsky, Bruce J. Giantonio, Kimberly Perez, Benjamin L. Schlechter, Jennifer Y. Wo, Hannah J. Roberts, Ryan Corcoran, David Ting, Jeffrey A. Meyerhardt, Elizabeth Kantrowitz, Sydney D. Ludes, Katharine Zecca, Lorraine C. Drapek, Arnav Mehta, Theodore S. Hong, Aparna R. Parikh

    Erschienen: 2026-11-03DOI: 10.1158/1078-0432.ccr-26-1261

  9. FIND: A Phase II Study to Evaluate the Efficacy and Safety of Erdafitinib in FGFR -Altered NSCLC

    Lucia Nogova, Florian Malchers, Axel M. Hillmer, Inken Terjung, Heather Scharpenseel, Anna Rasokat, Sabine Merkelbach-Bruse, Andreas H. Calaminus, Janna Siemanowski-Hrach, Matthias Scheffler, Julia Frank, Pierce Heiden, Thorsten Persigehl, Horst-Dieter Hummel, Jens Kern, Martin Wermke, Christian Grohe, Sebastian Michels, Richard Riedel, Anna Kron, Marlene Brodersen, Rieke N. Fischer, Anna Eisert, Theresa Reutter, Gregor Zadoyan, Andreas Draube, Martin Sebastian, Jens Panse, Niels Reinmuth, Frank Griesinger, Martin Hellmich, Roman K. Thomas, Reinhard Büttner, Jürgen Wolf

    Erschienen: 2026-11-03DOI: 10.1158/1078-0432.ccr-26-1485

  10. Complement-driven NETosis mediates immunotherapy resistance in STK11 -mutant lung adenocarcinoma

    Carlos E. de Andrea, Daniel Ajona, Cristina Sainz, Ana Remirez, Jose I. Echeveste, Ramon Amat, Juan P. de-Torres, Benjamin Solomon, Valerio Perna, Juan Dubrot, Javier Hernandez-Losa, Maria Rodriguez, Álvaro López-Janeiro, Allan Argueta, Maria D. Lozano, Álvaro Teijeira, Ignacio Melero, Fernando Lecanda, Leeat Keren, Luis M. Montuenga, Gavin Wright, Enriqueta Felip, Ruben Pio

    Erschienen: 2026-11-03DOI: 10.1158/1078-0432.ccr-26-1792

  11. Multi-institutional Patient-Level Comparison of Decipher Genomic Classifier and Artera Multimodal Artificial Intelligence in Prostate Cancer

    Boon Hao Hong, Adeniyi A. Olabumuyi, Shuang G. Zhao, Purvish Trivedi, Ryan Putney, Esther Katende, Amparo Serna, Riley Smith, Jasreman Dhillon, Jong Y. Park, Rodrigo Pessoa, Michael Poch, Daniel Grass, Julio Pow-Sang, Alexander Hakansson, Yang Liu, Elai Davicioni, Yi Ren, Siyi Tang, Danielle Croucher, Huei-Chung Huang, S. Laura Chang, Mary Feng, Rikiya Yamashita, Enya H.W. Ong, Kae Jack Tay, Kah Min Tan, Jeffrey K.L. Tuan, Michael L.C. Wang, Li Yan Khor, Olivia G. Jordan, Jinhee Chang, Claudia Datnow-Martinez, Xiaolei Shi, Amol Shetty, Zaker H. Rana, Jason K. Molitoris, Mark V. Mishra, Young Kwok, Yang Song

    Erschienen: 2026-11-03DOI: 10.1158/1078-0432.ccr-26-2269

  12. ERK1/2 Inhibitor Ulixertinib in Pancancer Patients with BRAF Fusions or Non-V600E/K Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1L

    Vivek Subbiah, Fengmin Zhao, Ragini R. Kudchadkar, Ryan J. Sullivan, Helen X. Chen, Robert J. Gray, Victoria Wang, Lisa M. McShane, Larry V. Rubinstein, David Patton, P. Mickey Williams, Stanley R. Hamilton, Tilak K. Sundaresan, Barbara A. Conley, James V. Tricoli, Carlos L. Arteaga, John J. Wright, Lyndsay N. Harris, Peter J. O’Dwyer, Alice P. Chen, Keith T. Flaherty

    Erschienen: 2026-11-02DOI: 10.1158/1078-0432.ccr-24-0951

  13. Neoadjuvant Nivolumab plus Carboplatin and Paclitaxel in Patients with Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck: A Phase II, Single-Arm Trial

    Ralph G. Zinner, Eric V. Mastrolonardo, Jennifer M. Johnson, Kathryn Nunes, Pablo Llerena, Zachary Elliott, Madalina Tuluc, Joseph M. Curry, Christopher E. Fundakowski, Andrew Yampolsky, Richard Goldman, Charalambos C. Solomides, Stacey M. Gargano, Haresh Naringrekar, Larry Harshyne, Dawn Poller, Benjamin E. Leiby, Voichita Bar-Ad, Rita Axelrod, Athanassios Argiris, Adam J. Luginbuhl, David M. Cognetti

    Erschienen: 2026-11-02DOI: 10.1158/1078-0432.ccr-25-2807

Jahrgänge

2026 · 2.4342025 · 6392024 · 5832023 · 5722022 · 6042021 · 1.1122020 · 1.4062019 · 9782018 · 1.1732017 · 1.1952016 · 1.0802015 · 1.0712014 · 7922013 · 9392012 · 1.0042011 · 8552010 · 1.0532009 · 9842008 · 1.0922007 · 1.0312006 · 1.0512005 · 1.1732004 · 1.118

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.